Simponi Injection 50 mg/0.5 ml contains Golimumab, a fully human monoclonal antibody that targets and neutralizes tumor necrosis factor-alpha (TNF-α), a key cytokine involved in inflammatory processes. By inhibiting TNF-α, Golimumab reduces inflammation, joint damage, and associated symptoms in autoimmune conditions.
Simponi is used in the treatment of chronic inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. The prefilled syringe allows for subcutaneous self-administration or administration by a healthcare professional, offering convenient dosing and improved adherence.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Reduces Inflammation: Inhibits TNF-α, decreasing swelling, pain, and joint damage.
Slows Disease Progression: Protects joints from further structural damage in rheumatoid arthritis and psoriatic arthritis.
Improves Physical Function: Enhances mobility, daily activity, and overall quality of life.
Convenient Administration: Prefilled syringe for easy subcutaneous injection.
Effective for Multiple Autoimmune Disorders: Approved for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Simponi Injection 50 mg/0.5 ml is indicated for:
Moderate to severe rheumatoid arthritis in adults, often in combination with methotrexate
Active psoriatic arthritis
Ankylosing spondylitis
Moderate to severe ulcerative colitis in adults
It is suitable for patients who require long-term disease-modifying therapy to control chronic inflammation and prevent progression of autoimmune conditions.
The recommended dosage should be individualized and administered under the guidance of a healthcare professional:
Typically administered as a subcutaneous injection of 50 mg once a month.
Can be given with or without methotrexate, depending on the condition and patient response.
Rotate injection sites between the thigh, abdomen, or upper arm to minimize local reactions.
Patients should be monitored regularly for signs of infection or adverse reactions.
Simponi Injection 50 mg/0.5 ml is generally well tolerated. Common side effects may include:
Injection site reactions (redness, swelling, pain)
Upper respiratory tract infections
Headache
Nausea
Serious but rare side effects may include severe infections (including tuberculosis), malignancies, liver problems, or allergic reactions. Prompt medical attention is required if severe symptoms occur.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Screen for latent tuberculosis before starting therapy.
Avoid live vaccines during treatment.
Use with caution in patients with a history of chronic infections or immunosuppression.
Inform your doctor about all medications to avoid potential interactions.
Pregnancy and breastfeeding use should be under medical supervision.
Store Simponi Injection 50 mg/0.5 ml in a refrigerator at 2–8°C. Do not freeze. Keep the prefilled syringe in the original carton to protect from light. Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet